Gilla Kaplan - Jun 17, 2025 Form 4 Insider Report for Tyra Biosciences, Inc. (TYRA)

Role
Director
Signature
/s/ Ali D. Fawaz, Attorney-in-Fact
Stock symbol
TYRA
Transactions as of
Jun 17, 2025
Transactions value $
-$93,700
Form type
4
Date filed
6/20/2025, 05:42 PM
Previous filing
Jun 16, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
KAPLAN GILLA Director C/O TYRA BIOSCIENCES, INC., 2656 STATE STREET, CARLSBAD /s/ Ali D. Fawaz, Attorney-in-Fact 2025-06-20 0001247024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TYRA Common Stock Sale -$104 -10 -0.03% $10.35 37.8K Jun 17, 2025 Direct
transaction TYRA Common Stock Sale -$93.6K -9.57K -25.31% $9.78 28.2K Jun 18, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.55 to $9.93. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.